News

We are pleased to announce the participation of SB BioAnalytica to the 1st Panhellenic Conference on Medical Genetics, with International participation, on October 14-16 ,2022, which will take place in a hybrid format at the Amphitheater of Physiology “G. Kotzias” at the School of Medicine , of the National Kapodistrian University of Athens. SB BioAnalytica, ...

We are pleased to announce the participation of SB BioAnalytica to the 7th International Meeting on Bone Marrow Adiposity (BMA 2022) which will be held this year in ATHENS Greece on September from 28th-30th, 2022 at the Amarilia Hotel . The scientific team of SB BioAnalytica invites you to the company’s stand to present  products ...

The Ultrio NAT TMA System is safeguarding Blood Transfusion in Greece against HIV-1, HBV, HCV. SafeBlood BioAnalytica SA, distributor of Novartis Diagnostics has established the ULTRIO NAT TMA System, screening more than 350.000 blood donations per year, having already protected more than 700 patients from risky Blood Transfusions. Especially for HIV-1 the ULTRIO NAT TMA ...

Our company, SafeBlood BioAnalytica, exclusive distributor of CERUS company, is happy to announce that the INTERCEPT Red Blood Cell System authorization study has entered in Phase III. The INTERCEPT Blood System for Red Cells will revolutionize Blood Transfusion Safety, securing blood transfusions from emerging or re-emerging pathogens! The INTERCEPT Blood System for Red Cells will ...

Safeblood Bioanalytica was succesfully participated in the “Genomic Medicine in the Mediterranean GM2” conference that took place in Heraklion, Crete from 2-5 Oct 2013. The conference dealt with the contribution of next generation technologies to genetic research, whilst the participants included students and young researchers  from all over the world. Our company represented “illumina” with ...